How can we improve amniocentesis decision-making?

被引：0
|
作者：
Lisa Soleymani Lehmann
机构：
[1] National Center for Ethics in Health Care,Department of Medicine
[2] Veterans Health Administration,Department of Global Health and Social Medicine
[3] Harvard Medical School,Department of Health Policy and Management
[4] Harvard Medical School,undefined
[5] Harvard T.H. Chan School of Public Health,undefined
来源：
Israel Journal of Health Policy Research | / 5卷
关键词：
Health Care Provider; Down Syndrome; Prenatal Screening; Nuchal Translucency; Screen Test Result;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The decision to have an amniocentesis entails a trade-off between a risk of procedure associated miscarriage and the benefit of obtaining diagnostic information to identify Down syndrome or other chromosomal aneuploidy. Ideally, this trade-off is informed by first and second trimester pre-natal screening tests, such that women with low risk screening test results are not encouraged to have an amniocentesis.
引用
收藏
相关论文
共 50 条
12345